Comparison of Safety and Efficacy between Venetoclax Combined with CAG (cytarabine, aclarubicin, G-CSF) Regimen and CAG Regimen Alone in Patients with Relapsed or Refractory Acute Myeloid Leukemia

被引：2
|
作者：
Yu, Wen-Jing [1 ]
Wu, Ying [1 ]
Chen, Qi [1 ]
Zhu, Xiaolu [1 ]
Pei, Xu-Ying [1 ]
Jia, Jin-Song [2 ]
Wang, Jing [1 ]
Zhao, Xiao-Su [1 ]
Chang, Ying-Jun [1 ]
Lai, Yue-Yun [1 ]
Shi, Hong-Xia [1 ]
Ruan, Guo-Rui [1 ]
Qin, Ya-Zhen [1 ]
Liu, Xiao-Hong [1 ]
Huang, Xiao Jun [1 ,3 ]
Jiang, Hao [1 ]
机构：
[1] Peking Univ, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Inst Hematol, Natl Clin Res Ctr Hematol Dis,Peoples Hosp, Beijing, Peoples R China
[2] Peking Univ, Inst Hematol, Peoples Hosp, Beijing, Peoples R China
[3] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184665
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia
    Qian, S.
    Li, J.
    Zhang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia
    Qian, Si-Xuan
    Li, Jian-Yong
    Tian, Tian
    Shen, Yun-Feng
    Jiang, Yuan-Qiang
    Lu, Hua
    Wu, Han-Xin
    Zhang, Su-Iiang
    Xu, Wei
    LEUKEMIA RESEARCH, 2007, 31 (10) : 1383 - 1388
  • [43] Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia
    Liu, Limin
    Jiao, Wenjing
    Zhang, Yanming
    Qu, Qi
    Li, Xiaoli
    Wu, Depei
    LEUKEMIA RESEARCH, 2015, 39 (03) : 323 - 328
  • [44] A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
    David Martínez-Cuadrón
    Blanca Boluda
    Pilar Martínez
    Juan Bergua
    Rebeca Rodríguez-Veiga
    Jordi Esteve
    Susana Vives
    Josefina Serrano
    Belen Vidriales
    Olga Salamero
    Lourdes Cordón
    Amparo Sempere
    Ana Jiménez-Ubieto
    Julio Prieto-Delgado
    Marina Díaz-Beyá
    Ana Garrido
    Celina Benavente
    José Antonio Pérez-Simón
    Federico Moscardó
    Miguel A. Sanz
    Pau Montesinos
    Annals of Hematology, 2018, 97 : 763 - 772
  • [45] CHAG priming regimen containing of cytarabine, aclacinomycin homoharringtonine and G-CSF for relapsed refractory acute myelogenous Leukemia: a modified combination chemotherapeutic combination
    Chen, Lin
    Yin, Qingsong
    Mi, Ruihua
    Wei, Xudong
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2291 - 2293
  • [46] G-CSF Priming, Clofarabine and High Dose Cytarabine (GCLAC) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Becker, Pamela S.
    Estey, Elihu
    Petersdorf, Stephen
    Storer, Barry E.
    Appelbaum, Frederick R.
    BLOOD, 2009, 114 (22) : 816 - 816
  • [47] Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia
    Shahswar, Rabia
    Beutel, Gernot
    Gabdoulline, Razif
    Schwarzer, Adrian
    Kloos, Arnold
    Koenecke, Christian
    Stadler, Michael
    Gohring, Gudrun
    Behrens, Yvonne Lisa
    Li, Zhixiong
    Dallmann, Louisa-Kristin
    Klement, Piroska
    Albert, Catherin
    Wichmann, Martin
    Alwie, Yasmine
    Benner, Axel
    Saadati, Maral
    Ganser, Arnold
    Thol, Felicitas
    Heuser, Michael
    HAEMATOLOGICA, 2024, 109 (01) : 72 - 83
  • [48] Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia
    Lu Xi Song
    Li Xu
    Xiao Li
    Chun Kang Chang
    Yi Zhang
    Ling Yun Wu
    Qi He
    Qing Xia Zhang
    Xiang Li
    Annals of Hematology, 2012, 91 : 1879 - 1886
  • [49] Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia
    Song, Lu Xi
    Xu, Li
    Li, Xiao
    Chang, Chun Kang
    Zhang, Yi
    Wu, Ling Yun
    He, Qi
    Zhang, Qing Xia
    Li, Xiang
    ANNALS OF HEMATOLOGY, 2012, 91 (12) : 1879 - 1886
  • [50] Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (FLAG regimen): A single center study
    Carella, AM
    Cascavilla, N
    Greco, MM
    Melillo, L
    Sajeva, MR
    Ladogana, S
    D'Arena, G
    Perla, G
    Carotenuto, M
    LEUKEMIA & LYMPHOMA, 2001, 40 (3-4) : 295 - 303
12345